#TeamTenaya recently hosted a safety contest that brought everyone together to refresh best practices through some friendly competition and teamwork. Keeping our work environment safe is our top priority! Check out some of the highlights of our time together. #TenayaTherapeutics #LabSafety #HeartDisease #HCM
Tenaya Therapeutics
生物技术研究
South San Francisco，California 16,577 位关注者
Scaling new heights in the fight against heart disease
关于我们
Tenaya Therapeutics is a clinical stage biotechnology company. The Company was founded in 2016 by leading cardiovascular scientists from the David J. Gladstone Institutes and the University of Texas Southwestern Medical Center. We are a biotechnology company committed to a bold mission: to discover, design, develop and deliver curative therapies that address the underlying drivers of heart disease. Our vision is to change the treatment paradigm for heart disease, and in doing so improve and extend the lives of millions of individuals and families fighting this debilitating disease. We are advancing a pipeline of disease-modifying therapies developed using our product platforms and core internal capabilities to target defined sub-populations of patients with rare or highly prevalent forms of heart disease.
- 网站
-
https://www.tenayatherapeutics.com
Tenaya Therapeutics的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- South San Francisco，California
- 类型
- 私人持股
- 创立
- 2016
- 领域
- Cardiovascular Disease、Heart Failure、Gene Therapy、Cardiomyopathies、In Vivo Cellular Reprogramming、iPSC-Cardiomyoctyes、Precision Medicine和Cellular Regeneration
地点
-
主要
获取路线
171 Oyster Point Blvd
US，California，South San Francisco，94080
Tenaya Therapeutics员工
动态
-
#TeamTenaya recently attended the American Heart Association Scientific Sessions, where we joined a global community of researchers, scientists, and patients dedicated to advancing heart health. We're pushing boundaries to make transformative medicines a reality. Learn more about our science here: https://bit.ly/4enIrmB #AHA2024 #HeartDisease #HCM
-
-
Sharing your story can be a powerful way to reach and support others living with #ARVC and #HCM. At Tenaya, our Patient Advocacy team works to elevate the voices of individuals living with #cardiomyopathy. To learn more about how to engage with us, email [email protected] #GeneticHeartDisease #ARVD #PatientsFirst
-
A powerful story from Boston Children’s Hospital highlights Kiersten’s journey managing arrhythmogenic right ventricular cardiomyopathy (#ARVC), a rare and life-threatening condition often driven by PKP2 gene mutations. Her experience underscores the importance of specialized care and the critical need for genetic testing in guiding treatment for ARVC. #TeamTenaya is developing investigational therapies to change the treatment paradigm for heart disease. Our mission is to improve and extend the lives of millions of individuals and families fighting these debilitating diseases. Read Kiersten’s story here: https://bit.ly/3Cevo9C #HeartDisease #Cardiomyopathy #GeneTherapy
-
At Tenaya, we are researching gene therapies for genetic heart conditions, like #ARVC. Tenaya’s investigational gene therapy is intended to target muscle cells in the heart to treat the underlying genetic cause of ARVC. Learn more about TN-401 and how it works by watching the full video: https://bit.ly/47YvVIS #GeneTherapy #HeartDisease #Tenaya #ARVC #PKP2
-
We are excited to sponsor the International #SADSFoundation Family Conference this weekend. We hope to see you there!?? ? In the meantime, check out www.ARVCstudies.com to learn more about our work in #ARVC.? ? #SADS #HeartDisease #ARVD?
It’s finally Conference week! If you’re coming to the conference, make sure to join us at our reception, where healthcare professionals and families can mingle, enjoy light refreshments, and get to know each other. Our reception this year will also feature a book signing by Katherine Standefer (books for sale provided by Secret World Books), as well as a short presentation by Thryv Therapeutics Inc. on their new research for #LQTS. If you aren’t joining us in-person, make sure to stay tuned to our social media – we will be doing an interview with Thryv on Instagram and Facebook stories! Learn more about our conference at https://lnkd.in/gdsP9tzG. Our reception is generously sponsored by Thryv Therapeutics.
-
-
We reported third quarter financial results and provided business and program updates. Read more: https://bit.ly/3YUVxn6 #TenayaTherapeutics #GeneTherapy #HeartDisease
-
ICYMI: Team Tenaya joined the virtual HCM Society (HCMS) Scientific Sessions where we presented new research on the disease burden for those living with MYBPC3-associated hypertrophic cardiomyopathy (#HCM).
-
#TeamTenaya recently joined the American Heart Association's 2024 Bay Area Heart Walk to support a future free of heart disease. As a team founded by leading cardiovascular scientists, we are driven by the same mission behind this event — working to transform the treatment of heart disease and improve lives. ?? #HeartWalk #HeartDisease #HCM
-